Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen
- 1 June 1998
- journal article
- Published by Elsevier in Kidney International
- Vol. 53 (6) , 1626-1630
- https://doi.org/10.1046/j.1523-1755.1998.00909.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The role of host immune responses in determining the outcome of HIV infectionImmunology Today, 1996
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- Association of Mucosal Leishmaniasis with HLAHuman Immunology, 1991
- Common West African HLA antigens are associated with protection from severe malariaNature, 1991
- Immunogenetics of human american Cutaneous LeishmaniasisHuman Immunology, 1991
- Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patientsJournal of Hepatology, 1990
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cellsHuman Immunology, 1988
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- HLA-A1, B8-Phenotype Association and HBs Antigenemia Evolution in 440 Hemodialyzed PatientsDigestion, 1977